Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.5 USD | -1.51% | -5.88% | +0.18% |
06/05 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |
06/05 | Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.18% | 2.64B | |
+27.61% | 48.16B | |
-0.71% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.81% | 25.59B | |
-22.67% | 18.96B | |
+8.03% | 12.92B | |
+29.60% | 12.03B | |
-2.24% | 11.77B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics : HC Wainwright Adjusts Celldex Therapeutics' Price Target to $54 From $50, Reiterates Buy Rating